Excelsior Capital Club
About Excelsior Capital Club
We partner with outside firms to bring you exclusive access to alternative investment opportunities, premium content and education, and an affinity peep-to-peer network of industry professionals.
In this hour long online session, we will be hosting four guest presenters that will introduce their investment opportunities, allowing time at the end for open discussion and Q&A.
To Learn and Grow
In addition to our pitches, you’ll have the opportunity to network with like-minded professionals and a community of industry trends.
A new way to access alternative investment opportunities.
How It Works
We will be hosting all pitches through a Zoom webinar that we will release each month. Register online to gain access and receive materials to review beforehand.
Each month, we will host an hour-long pitch session with four presenters that will introduce their investment opportunities, allowing time at the end for open discussion and Q&A.
Expand Your Network
Following each pitch, you’ll be included in a new network of like-minded investment professionals. We’ll leave it up to you to connect with others as you grow your network.
Join Excelsior Capital Club
Subscribe to be the first to receive updates on new pitches!
Upcoming Pitch Details
In our next Excelsior Capital Club pitch, you’ll have the opportunity to hear from our presenters: Raphael Martorello, Scott Rader and Andrew Gluck.
LotusGroup Longevity Fund
Deal Sector: Life Settlements
Total Raise: $69M
LotusGroup Capital (“LGC”) was founded in 2018 out of the private alts group of sister firm LotusGroup Advisors (collectively “LotusGroup”). LotusGroup has a 17-year regulatory track record and both firms are registered as RIAs with the SEC. Led by CIO Mr. Raphael Martorello, LGC’s Asset Management Team is comprised of professionals in life settlement sourcing,
valuation, closing, servicing, portfolio management, and actuarial modeling. Combined, the team has over 50 years of life settlements experience and has transacted and managed several billion dollars of life settlements.
The LotusGroup Longevity Fund is a differentiated life settlements strategy. The fund focuses on producing uncorrelated yield and total returns to traditional investments.
Presented By: Raphael Martorello | Connect on Linkedin
Deal Sector: Venture Capital and Private Equity
Total Raise: $1M
Solas BioVentures focuses on early stage biopharmaceuticals, medical devices, diagnostics, digital health technologies and related opportunities in medicine. The Investment Team combines decades of medical, biotechnology, operational, managerial, and financial experiences as well as having been profitably engaged in investing in these same types of companies independently. The Team involves the Solas Limited Partners from the medical field when reviewing opportunities in their area of clinical expertise.
Presented By: Scott Rader | Connect on Linkedin
Deal Sector: Early-stage VC Fund
Total Raise: $250-500K
irrvrntVC invests $250K-$500K at the earliest stages in DTC, AdTech, & NextGen Commerce companies. irrvrnt is a Solo Capitalist fund led by Andrew Gluck. Andrew spent the last three years angel investing in some of the most successful early-stage companies including Lunchbox, Caraway, Branch, Coop Commerce, and more. Prior to that he co-founded and ran Agency Within, the largest independent digital marketing agency with a focus on direct-response, data-driven marketing, where he managed $1B+ in spend for clients like Nike, Billie and Zola.
Presented By: Andrew Gluck | Connect on Linkedin
Excelsior Capital and Brian C. Adams are not an investment advisory service and is not a registered investment advisor or broker/dealer and has performed no due diligence and does not endorse any investment services, strategies, managers or investments listed on the Excelsior Capital Club.You should perform your own extensive due diligence.
104 Woodmont Blvd, Suite 203
Nashville, TN 37205
Disclaimer: Under no circumstances should any information presented on this website be construed as an offer to sell, or solicitation of an offer to purchase any securities or other investments. This website does not contain the information that an investor should consider or evaluate to make a potential investment. Other materials related to investments in entities managed by Excelsior Capital are not available to the general public.